NLE Hematologic Nursing — Bleeding, Clotting and Hematologic MalignanciesSummary
Bleeding, Clotting and Hematologic Malignancies is one of the highest-yield Hematologic Nursing topics for the NLE. Professional Regulation Commission (PRC) — Board of Nursing has included questions from this chapter in every recent NLE 2026 cycle, so understanding the core ideas and common traps is essential for improving your mock score. This summary walks through what Bleeding, Clotting and Hematologic Malignancies is about, the big concepts, the formulas that matter, and how NLE frames questions on this topic.
Exam context
On the NLE 2026, the Hematologic Nursing subtest carries a "Core" weight in Professional Regulation Commission (PRC) — Board of Nursing's pattern. Bleeding, Clotting and Hematologic Malignancies lands at position 2nd out of 2 in the standard review order. Target score is 75% weighted average with no sub-test below 60%, and roughly 50 items come from Hematologic Nursing on a typical NLE paper.
Bleeding, Clotting and Hematologic Malignancies - Summary
Auto-generated chapter summary
Raw Response
```json { "title": "Bleeding, Clotting and Hematologic Malignancies: Comprehensive Chapter Summary for NLE Preparation", "introduction": "This chapter addresses critical hematologic disorders that are high-stakes topics in the Philippine Nursing Licensure Examination (NLE) because they involve life-threatening bleeding, severe infection, organ failure, and the complex management of blood products. As a Filipino BSN graduate preparing for clinical practice under RA 9173 (Philippine Nursing Ac
Ready to practise for the NLE 2026?
Super Tutor's AI review plan adapts to your weak areas and builds a weekly practice schedule around your target NLE exam date.